background image

Paid Clinical Trials Morgantown

Discover 281 paid clinical trials in Morgantown, West Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer.

Recruiting

Sponsor:

University College, London

Location:

Morgantown WV, Cleveland OH, Detroit MI, Dobbs Ferry NYshow 4 more

Code:

NCT01792726

Conditions

Early Breast Cancer

Eligibility Criteria

Sex: Female

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Boost to the tumour bed

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

Recruiting
PHASE3

Sponsor:

Chimerix

Location:

Pittsburgh PA, Fairfax VA, Cleveland OH, Columbus OHshow 53 more

Code:

NCT05580562

Conditions

H3 K27M

Glioma

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Dordaviprone (ONC201)

Dordaviprone (ONC201) + Placebo

Placebo

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Recruiting

Sponsor:

Nicole Hamblett

Location:

Morgantown WV, Pittsburgh PA, Fairfax VA, Cleveland OHshow 58 more

Code:

NCT06504589

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Recruiting
PHASE3

Sponsor:

Shanghai Henlius Biotech

Location:

Morgantown WV, Canton OH, Massillon OH, Akron OHshow 85 more

Code:

NCT05468489

Conditions

Extensive Stage Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Serplulimab + chemotherapy (carboplatin-etoposide)

Atezolizumab + chemotherapy (carboplatin-etoposide)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Morgantown WV, Bridgeport WV, Jefferson Hills PA, Bryn Mawr PAshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Prospective Evaluation of Adjusted Body Weight Dosing of Acyclovir in Obesity

Recruiting

Sponsor:

West Virginia University

Location:

Morgantown WV

Code:

NCT02879630

Conditions

Obesity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

Recruiting
PHASE2

Sponsor:

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA

Location:

Morgantown WV, Pittsburgh PA, Falls Church VA, Cleveland OHshow 49 more

Code:

NCT04945460

Conditions

Hypertension, Pulmonary

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sotatercept 0.3 mg/kg

Placebo

Sotatercept 0.3 mg/kg escalating to 0.7 mg/kg

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting
PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Pittsburgh PA, Falls Church VA, Columbus OH, Washington DCshow 87 more

Code:

NCT06003426

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo

Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)

Recruiting

Sponsor:

Vertex Pharmaceuticals Incorporated

Location:

Morgantown WV, Akron OH, Cleveland OH, Richmond VAshow 22 more

Code:

NCT06506773

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 0 - 6

Healthy Volunteers: Not accepted

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Recruiting
PHASE3

Sponsor:

Takeda

Location:

Pittsburgh PA, Cleveland OH, Roanoke VA, Baltimore MDshow 22 more

Code:

NCT04779320

Conditions

Crohn's Disease (CD)

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

Vedolizumab IV